Emergent BioSolutions Inc
SWB:ER4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Emergent BioSolutions Inc
SWB:ER4
|
US |
|
O
|
Optivision Technology Inc
TPEX:3666
|
TW |
|
O-I Glass Inc
NYSE:OI
|
US |
|
A
|
Aquila Part Prod Com SA
XBSE:AQ
|
RO |
|
A
|
Aldeyra Therapeutics Inc
SWB:137
|
US |
|
A
|
Adaptive Biotechnologies Corp
DUS:1HM
|
US |
|
B
|
BAWAG Group AG
F:0B2
|
AT |
|
Sansan Inc
OTC:SNSNF
|
JP |
|
B
|
Beowulf Mining PLC
SWB:B4E
|
UK |
|
B
|
BAWAG Group AG
VSE:BG
|
AT |
|
L
|
Land Securities Group PLC
F:LSU2
|
UK |
|
True North Copper Ltd
ASX:TNC
|
AU |
|
AVITA Medical Inc
F:51KB
|
US |
Bankruptcy Probability
Emergent BioSolutions Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Emergent BioSolutions Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Emergent BioSolutions Inc
NYSE:EBS
|
374m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
208B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Emergent BioSolutions Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Emergent BioSolutions Inc has total debt of 573.6m USD. This includes both short-term (0 USD) and long-term (573.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
